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Abstract: Iron homeostasis offers a significant bacterial vulnerability because pathogens obtain
essential iron from their mammalian hosts, but host-defenses maintain vanishingly low levels of
free iron. Although pathogens have evolved mechanisms to procure host-iron, these depend on
well-regulated iron homeostasis. To disrupt iron homeostasis, our work has targeted iron mobilization
from the iron storage protein bacterioferritin (BfrB) by blocking a required interaction with its cognate
ferredoxin partner (Bfd). The blockade of the BfrB–Bfd complex by deletion of the bfd gene (∆bfd)
causes iron to irreversibly accumulate in BfrB. In this study we used mass spectrometry and NMR
spectroscopy to compare the proteomic response and the levels of key intracellular metabolites between
wild type (wt) and isogenic ∆bfd P. aeruginosa strains. We find that the irreversible accumulation
of unusable iron in BfrB leads to acute intracellular iron limitation, even if the culture media is
iron-sufficient. Importantly, the iron limitation and concomitant iron metabolism dysregulation
trigger a cascade of events that lead to broader metabolic homeostasis disruption, which includes
sulfur limitation, phenazine-mediated oxidative stress, suboptimal amino acid synthesis and altered
carbon metabolism.
Keywords: iron homeostasis; iron metabolism; sulfur metabolism; Pseudomonas aeruginosa; ferritin;
bacterioferritin; ferredoxin; proteomics

1. Introduction
Pseudomonas aeruginosa is an opportunistic pathogen causative of severe infections, particularly
in health care settings and in immunocompromised patients. The emergence and dissemination of
multidrug-resistant Pseudomonas aeruginosa strains is a significant threat to public health [1–3]. The World
Health Organization included carbapenem-resistant P. aeruginosa in its priority list of pathogens for
which new antibiotics are urgently needed [4]. To combat the threat posed by multidrug-resistant
organisms, there is an urgent need to discover novel antibiotics and validate new targets in antibacterial
research [5–7]. A new approach to combat infection currently under investigation is to capitalize on
the iron requirement of pathogens for establishing infections [8–14]. Iron is essential because of its
requirements of enzymes mediating respiration, DNA synthesis, amino acid synthesis and many other
key metabolic processes [15]. Pathogens must obtain iron from their host, but host nutritional immunity
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host, but host nutritional immunity denies the essential nutrient by maintaining very low
denies the essential nutrient by−20maintaining very low concentrations of free iron (~10−20 M) [15].
concentrations of free iron (~10 M) [15]. The chemical properties of iron also present challenges to
The chemical properties of iron also present challenges to invading2+ pathogens in that the reactivity
invading pathogens in that the reactivity of the ferrous ion (Fe ) toward H2O2 and O2 induces
of the ferrous ion (Fe2+ ) toward H2 O2 and O2 induces oxidative stress. Consequently, bacterial iron
oxidative stress. Consequently, bacterial iron homeostasis (iron acquisition, storage and utilization)
homeostasis (iron acquisition, storage and utilization) is highly regulated to ensure sufficiency for
is highly regulated to ensure sufficiency for metabolic needs while preventing iron-induced toxicity
metabolic needs while preventing iron-induced toxicity [16,17].
[16,17].
The struggle for iron between host and bacteria has given rise to the idea of exploiting iron
The struggle for iron between host and bacteria has given rise to the idea of exploiting iron
metabolism as a potentially viable approach to develop new antibiotics. Approaches that follow
metabolism as a potentially viable approach to develop new antibiotics. Approaches that follow this
this general idea include the development of siderophore conjugates to enhance antibiotic cell
general idea include the development of siderophore conjugates to enhance antibiotic cell penetration
penetration [18,19], the sequestration of iron with chelators to deplete intra- and extracellular
[18,19], the sequestration of iron with chelators to deplete intra- and extracellular iron [13,20–23], the
iron [13,20–23], the perturbation of heme uptake or heme degradation to deny the pathogens a
perturbation of heme uptake or heme degradation to deny the pathogens
a rich iron source during
rich iron source during infections [12,24], and
the utilization of Ga3+ , which is aimed at systemically
3+, which is aimed at systemically replacing Fe3+ with Ga3+
infections [12,24],
and
the
utilization
of
Ga
replacing Fe3+ with Ga3+ in the active site of enzymes [25,26]. Dysregulation of iron metabolism is also
in the active site of enzymes [25,26]. Dysregulation of iron metabolism is also thought to offer a
thought to offer a significant vulnerability. To disrupt iron metabolism, our laboratories are studying
significant vulnerability. To disrupt iron metabolism, our laboratories are studying a new and specific
a new and specific target in Pseudomonas aeruginosa, a protein–protein interaction between the iron
target in Pseudomonas aeruginosa, a protein–protein interaction between the iron storage protein
storage protein bacterioferritin (BfrB) and its physiological partner, the bacterioferritin-associated
bacterioferritin (BfrB) and its physiological partner, the bacterioferritin-associated ferredoxin (Bfd)
ferredoxin (Bfd) [27]. Our work has demonstrated that although two ferritin-like proteins (FtnA and
[27]. Our work has demonstrated that although two ferritin-like proteins (FtnA and BfrB) coexist in
BfrB) coexist in P. aeruginosa [28], BfrB is the main iron storage protein [16]. BfrB is a spherical molecule
P. aeruginosa [28], BfrB is the main iron storage protein [16]. BfrB is a spherical molecule assembled
assembled from 24 subunits which contains an interior cavity ~80 Å in diameter where up to ~3000
Fe3+
from 24 subunits which contains an interior cavity ~80 Å in diameter where up to ~3000 Fe3+ ions can
ions can be stored (Figure 1A). The BfrB structure also harbors heme molecules sandwiched between
be stored (Figure 1A). The BfrB structure also harbors heme molecules sandwiched between two
two subunits, buried under the external protein surface [27,29]. The mobilization of iron stored in BfrB
subunits, buried under the external protein surface [27,29]. The mobilization of iron stored in BfrB
requires Bfd. The X-ray crystal structure of the BfrB–Bfd complex revealed that up to 12 Bfd molecules
requires Bfd. The X-ray crystal structure of the BfrB–Bfd complex revealed that up to 12 Bfd molecules
can bind at identical sites on the BfrB surface, between two subunits, and immediately above a heme
can bind at identical sites on the BfrB surface, between two subunits, and immediately above a heme
molecule. The function of the heme is to facilitate electron transfer from the [2Fe-2S] cluster in Bfd to
molecule. The function of the heme is to facilitate electron transfer from
the [2Fe-2S] cluster in Bfd to
the Fe3+
stored in the interior cavity, thus facilitating the release of Fe2+ to the cytosol (Figure 1B) [30].
the Fe3+ stored in the interior cavity, thus facilitating the release of Fe2+ to the cytosol (Figure 1B) [30].
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biofilm-embedded cells exhibit cytosolic iron deficiency [14]. Given that P. aeruginosa cells require
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exhibit cytosolic iron deficiency [14]. Given that P. aeruginosa cells require sufficient intracellular iron to
establish mature biofilms [31], it was suggested that the irreversible accumulation of iron in BfrB in the
∆bfd cells causes iron limitation, even in iron-sufficient conditions [14]. Similarly, challenging planktonic
cells with small molecule inhibitors of the BfrB–Bfd complex causes nearly irreversible accumulation
of iron in BfrB, a growth phenotype and pyoverdine hyper production [10].
Although these observations were interpreted to suggest that the blockade of the BfrB–Bfd complex
may result in iron metabolism dysregulation that adversely affects P. aeruginosa fitness, the connections
between iron metabolism dysregulation and cellular metabolic homeostasis are not yet known [10].
To begin understanding these connections, we interrogated the global cellular response to blocking the
BfrB–Bfd complex in P. aeruginosa by comparing the proteomic profiles of wt and ∆bfd cells cultured in
iron-sufficient media. We found that blocking the BfrB–Bfd complex indeed leads to iron metabolism
dysregulation and systemic iron limitation. The lesion in iron metabolism triggers a cascade of events,
leading to phenazine overproduction and associated redox stress, which impose iron and sulfur
limitation, altered carbon metabolism and suboptimal amino acid biosynthesis.
2. Results and Discussion
Deletion of the bfd gene results in the irreversible accumulation of iron in BfrB and concomitant
low iron levels in the cytosol [16]. These observations, however, did not indicate whether the low iron
levels are confined to the free iron pool in the cytosol, or if iron limitation also affects iron-dependent
proteins and the processes in which these proteins participate. Answering this question requires
that the experimental approach enable a relatively global assessment of the bacterial cell response to
blocking the BfrB–Bfd complex. Consequently, we compared the proteomic profiles of the wild type
(wt) P. aeruginosa PAO1 and the isogenic ∆bfd mutant cultured under identical conditions. As indicated
above, both strains grow at the same rate and to a nearly identical cell density when cultured in
iron-sufficient media. During the stationary growth phase, however, the ∆bfd cells secrete several-fold
more pyoverdine than the wt cells because of relatively low cytosolic iron levels [16]. Consequently,
we harvested the cells 30 h post inoculation when the ∆bfd cells secreted approximately sixfold more
pyoverdine than their wt counterparts (Figure S1). To compare the proteomic profiles of the wt and
∆bfd mutant cells, we carried out Tandem Mass Tag (TMT) labeling, an isobaric covalent modification
of primary amines which enables relative quantification of proteins across multiple samples [32],
upstream of the mass spectrometric analysis. This approach allowed us to identify and quantitate 3210
proteins, approximately 54% of the total 5570 proteins in P. aeruginosa [33]. Three biological replicates
and experimental (three each) replicates were incorporated so that t-tests were performed on the 3210
proteins to determine significant differences in protein abundance between wt and ∆bfd cells (p < 0.05).
Proteins exhibiting a ∆bfd/wt fold change (FC) ≥ 1.4 (log2 FC ≥ 0.5) are considered enriched in the ∆bfd
cells, and proteins with a ∆bfd/wt FC ≤ 0.7 (log2 FC ≤ −0.5) are considered depleted [34]. The results are
summarized in a volcano plot (Figure 2) where the segmented vertical lines indicate log2 FC ± 0.5 and
the horizontal segmented line denotes p = 0.05. Of the 3210 identified proteins, 296 (~9%) are above or
below the cutoff, 159 are enriched (128 p < 0.05) and 137 are depleted (96 p < 0.05) in ∆bfd relative to
wt cells.
The differentially expressed proteins were functionally categorized using the Kyoto Encyclopedia
of Genes and Genomes (KEGG) Orthology classification [35] (Figure 2B), the Pseudomonas Genome
Database [36], and the UniProt database [37]. This analysis revealed that the inhibition of the
BfrB–Bfd complex causes significant changes in the proteins involved in iron metabolism (Table S1).
The significant enrichment of proteins involved in iron and heme acquisition in the ∆bfd relative to the
wt cells is consistent with a strong iron starvation response caused by the irreversible accumulation
of iron in BfrB when the BfrB–Bfd complex is inhibited [16]. Accordingly, proteins involved in the
biosynthesis of 4-hydroxy-2-alkylquinolines (HAQs) and phenazines are also enriched in the ∆bfd
cells. Importantly, the data also reveal strong connections between the iron starvation response and
carbon metabolism, sulfur metabolism, amino acid biosynthesis, respiration, oxidative stress defense,
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Figure 2. (A) Volcano plot illustrating differentially abundant proteins in the ∆bfd isogenic mutant
relative to the wt strain. The fold change (FC) is defined as the abundance ratio of ∆bfd/wt. The non-axial
vertical lines designate log2 FC ± 0.5 and the non-axial horizontal line denotes p = 0.05. Points in
red represent proteins more abundant in the ∆bfd mutant, while points in blue indicate proteins
less abundant in the mutant. (B) KEGG Orthology functional classification of proteins differentially
expressed in wt and ∆bfd cells.

2.1. Inhibition of Iron Mobilization from BfrB Elicits a Global Iron Starvation Response
2.1.1. Pyoverdine Biosynthesis
The ∆bfd cells overproduce pyoverdine (Figure S1), a siderophore secreted by P. aeruginosa to
assimilate iron [38]. Pyoverdine molecules are composed of three main parts, a dihydroquinoline
chromophore (fluorescent), a strain-specific peptide, and a side chain stemming from the chromophore.
P. aeruginosa produces three pyoverdines (PVDI-III), each characterized by a different peptide chain [39];
PVDI (PVD hereafter) is the best characterized. PVD biosynthesis, schematically summarized in
Figure 3, requires numerous enzymes and non-ribosomal peptide synthetases (NRPSs) [38,40,41].
Inspection of Figure 3 shows that all the enzymes and non-ribosomal peptides involved in the
biosynthesis, secretion and import of the iron–PVD complex are strongly enriched in the ∆bfd cells,
as indicated by the color scale. The PVD backbone begins assembly in the cytosol with the aid of NRPSs,
PvdA, PvdD, PvdF, PvdH, PvdI, PvdJ and PvdL. The cytoplasmic (non-fluorescent) PVD precursor
bound to a myristic or myristoleic acid chain [42] is thought to be transported into the periplasm
by the ABC transporter PvdE [43], which is also highly enriched in the ∆bfd cells. The maturation
of PVD occurs in the periplasm where PvdQ cleaves the myristic or myristoleic moiety to produce
ferribactin, which is maturated by enzymes PvdN, PvdM, PvdO, and PvdP, all significantly enriched
in the ∆bfd cells. The siderophore is secreted through a tripartite efflux pump consisting of an
inner membrane protein (PvdT), periplasmic adaptor protein (PvdR) and outer membrane protein
(OpmQ) [41,44,45]. The secreted PVD chelates Fe3+ and the complex is taken into the periplasm by
FpvA in a TonB-dependent manner [46,47], where it binds to periplasmic proteins FpvC and FpvF.
The cytoplasmic membrane protein FpvG is thought to reduce the chelated Fe3+ , probably aided
by proteins FpvH, FpvJ, and FpvK [48]. After its dissociation from PVD, Fe2+ binds to FpvC and is
transported to the cytoplasm by the ABC transporter FpvDE, and PVD is recycled into the extracellular
space via the PvdT–PvdR–OpmQ efflux pump. We also observe that the sigma factor PvdS, required for
the expression of pyoverdine, is enriched in the ∆bfd cells, whereas the anti-sigma factor FpvR, which is
required to inactive PvdS, is strongly attenuated. As such, the proteomic profiles are in excellent
agreement with the pyoverdine overproduction of the ∆bfd relative to the wt cells.
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L-cysteine to form the second thiazoline ring, which is reduced to thiazolidine by PchG, before PchF
release of pyochelin [53]. The synthesis of PCH takes place in the cytosol, but not much is yet known
catalyzes the release of pyochelin [53]. The synthesis of PCH takes place in the cytosol, but not
regarding the proteins involved in its secretion, or the import of iron-bound PCH. In this context,
much is yet known regarding the proteins involved in its secretion, or the import of iron-bound PCH.
Figure 4B shows the organization of genes involved in pyochelin biosynthesis and function [50],
In this context, Figure 4B shows the organization of genes involved in pyochelin biosynthesis and
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2.1.3. Heme Uptake
P. aeruginosa utilizes two systems to scavenge host-heme, a hemophore-dependent heme
assimilation system (has) and a non-hemophore-dependent Pseudomonas heme uptake (phu)
system [54,55]. Heme is extracted from hemoglobin by the TonB-dependent PhuR receptor for
transport across the outer membrane. In the periplasmic space heme is shuttled by PhuT to the
PhuUVW transporter for internalization into the cytosol, where it is sequestered by PhuS and
transferred to the heme oxygenase (HemO) [56], which cleaves the heme macrocycle to release iron,
biliverdin-β, biliverdin-δ and carbon monoxide [57]. Consistent with the iron starvation caused by the
blockade of the BfrB–Bfd complex, most of the enzymes involved in heme capture, internalization and
heme degradation are enriched in the ∆bfd cells (Figure 5).
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Figure 4. Proteins for the synthesis and function of pyochelin are enriched in the Δbfd cells. (A)
Schematic depiction of pyochelin (PCH )biosynthesis, which starts with chorismate and requires two
equivalents of L-cysteine. The relative abundance (Δbfd/wt) of each of the proteins involved in PCH
biosynthesis is color coded according to the log2FC scale. (B) Organization of the genes encoding
proteins for PCH biosynthesis and function color coded according to the log2FC scale.
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degradation are enriched in the Δbfd cells (Figure 5).
2.1.3. Heme Uptake
P. aeruginosa utilizes two systems to scavenge host-heme, a hemophore-dependent heme
assimilation system (has) and a non-hemophore-dependent Pseudomonas heme uptake (phu) system
[54,55]. Heme is extracted from hemoglobin by the TonB-dependent PhuR receptor for transport
across the outer membrane. In the periplasmic space heme is shuttled by PhuT to the PhuUVW
transporter for internalization into the cytosol, where it is sequestered by PhuS and transferred to the
heme oxygenase (HemO) [56], which cleaves the heme macrocycle to release iron, biliverdin-β,
biliverdin-δ and carbon monoxide [57]. Consistent with the iron starvation caused by the blockade of
the BfrB–Bfd complex, most of the enzymes involved in heme capture, internalization and heme
degradation are enriched in the Δbfd cells (Figure 5).

Figure 5. Proteins for heme capture, internalization and release of heme-iron are enriched in the ∆bfd
cells. The relative abundance (∆bfd/wt) of the proteins involved in these processes is indicated by the
color according to the log2 FC scale. Outer membrane (OM), inner membrane (IM).
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2.1.4. Pseudomonas Quinolone Signal
The conditions of iron starvation are known to stimulate the biosynthesis of 2-alkyl-4-quinolones
(AQs), such as HHQ (2-heptyl-4-hydroxyquinolone), PQS (2-heptyl-3-hydroxy-4-quinolone) and HQNO
(2-heptyl-4-hydroxyquinoline-N-oxide). The pqs system (Figure 6A) encompasses the pqsR gene,
the pqsABCDE-phnAB operon and the distally located pqsH and pqsL genes [58]. The enzymes coded by
the pqs system synthesize HHQ and PQS, which stimulate the expression of the pqs operon [59]. Low iron
conditions stimulate the biosynthesis of AQs by at least two mechanisms: (i) the iron starvation σ factor
PvdS increases transcription of pqsR via an iron starvation box [60,61], and (ii) the PrrF sRNAs (PrrF1 and
PrrF2), which are expressed under low iron conditions, repress the transcription of genes coding
for enzymes that catalyze the degradation of anthranilate (antABC and catBCA), therefore sparing
anthranilate for the biosynthesis of AQs [62,63]. The biosynthetic process, schematically shown
in Figure 6B, starts when PqsA converts anthranilate into anthraniloyl-CoA, which is converted to
2-aminobenzoylacetyl-CoA (2-ABA-CoA) by PqsD and then to 2-aminobenzoylacetate (2-ABA) by PqsE.
The condensation of 2-ABA with octanoyl-CoA, catalyzed by the PqsBC heterodimer, forms HHQ.
Under aerobic conditions HHQ is oxidized to PQS by the enzyme PqsH, whereas the biosynthesis
of HQNO, which is also produced from 2-ABA, requires the monooxygenase PqsL and the PqsBC
heterodimer [64,65].
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2.1.5. Phenazines

Although P. aeruginosa can produce up to five different phenazine derivatives [67,68], pyocyanin
(PYO) is the most studied phenazine in this organism. Phenazine biosynthesis is carried out by
enzymes produced from the transcription of two similar operons, phzA1B1C1D1E1F1G1 (phz1) and
phzA2B2C2D2E2F2G2 (phz2) [67]. HHQ and PQS are known to positively regulate the expression of
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All the enzymes involved in the conversion of anthranilate to HHQ (pqsABCDE) are enriched
in the ∆bfd cells. In contrast, the enzyme required to convert 2-ABA to 2-HABA (PqsL) was not
detected, and the enzyme required to convert HHQ to PQS (PqsH) is expressed in the ∆bfd cells at
the same levels as in the wt cells (Figure 6B). In order to understand how this pattern of relative
protein expression is manifested in the levels of AQs produced by the wt and ∆bfd cells, we used liquid
chromatography-mass spectrometry (LC-MS) to quantitate HHQ, PQS and HQNO in the cells and in
the cell-free supernatants. These values, normalized to CFU/mL to enable comparisons (Figure 6C,D),
demonstrate that the ∆bfd cells produce significantly higher levels of AQs than the wt cells, observations
that agree with the enrichment of enzymes encoded by the pqsABCDE genes in the mutant. It is also
interesting to consider that HHQ and PQS are produced and secreted by the ∆bfd cells at relatively
similar levels, despite the observation that PqsH is not enriched in ∆bfd relative to wt. This is probably
because the abundance of HHQ in the ∆bfd cells stimulates the activity of PqsH, thus producing
relatively high levels of PQS, even if the enzyme is not enriched relative to the wt cells. Along the same
vein, the abundance of HHQ in the ∆bfd cells probably stimulates the activity of PqsL (not detected)
by channeling a fraction of 2-ABA toward 2-HABA, which is converted to HQNO by the PqsBC
heterodimer. It is tempting to speculate that the relatively low levels of HQNO relative to HHQ and
PQS suggest that the synthesis of HQNO is throttled down, possibly by maintaining low levels of the
PqsL enzyme.
Anthranilate, the first committed precursor in the biosynthesis of AQs, can be synthesized from
shikimate by AroCK and the anthranilate synthases PhnAB and TrpEG, or via the kynurenine pathway
that converts tryptophan into anthranilate [66] (see Figure 6B). We observed no changes in the levels of
enzymes involved in the kynurenine pathway or in the enzymes that convert shikimate to anthranilate
between wt and ∆bfd cells. This is most likely because the peptone in PI media is a rich source of
tryptophan, which can be used for anthranilate biosynthesis.
Iron limiting conditions are thought to spare anthranilate for the biosynthesis of AQs by
downregulating AntABC and CatABC, the enzymes implicated in the first steps of anthranilate
degradation for its incorporation in the TCA cycle [62]. We did not detect AntABC and CatABC
in our experiments; nevertheless, the enrichment of enzymes involved in the biosynthesis of AQs,
the higher levels of AQs found in the ∆bfd cells, and the “normal” production of anthranilate in the ∆bfd
cells, corroborate that when experiencing iron limitation, P. aeruginosa cells indeed utilize anthranilate
resources for the biosynthesis of AQs.
2.1.5. Phenazines
Although P. aeruginosa can produce up to five different phenazine derivatives [67,68],
pyocyanin (PYO) is the most studied phenazine in this organism. Phenazine biosynthesis is carried
out by enzymes produced from the transcription of two similar operons, phzA1B1C1D1E1F1G1 (phz1)
and phzA2B2C2D2E2F2G2 (phz2) [67]. HHQ and PQS are known to positively regulate the expression of
phz1 and phz2 [69], and recent studies have shown that the enzyme PqsE also stimulates transcription of
the phz1 and phz2 operons [65]. As such, iron limitation, which stimulates the pqsABCDE-phnAB operon
(see above), is also expected to stimulate transcription of the phz operons via HHQ, PQS and PqsE, all of
which are enriched in the ∆bfd cells (see Figure 6). In agreement with this idea, the data presented in
Figure 7 show that several of the enzymes encoded by genes in the phz1 and phz2 operons are enriched
in the ∆bfd cells relative to wt. The enrichment of enzymes coded by both operons is also in agreement
with a previous report demonstrating that enzymes from the phz1 and phz2 operons participate in the
biosynthesis of phenazine-1-carboxylic acid (PCA) in planktonic cells [70]. Inspection of Figure 7B
shows that in the path converting chorismic acid to PCA, at least one of the required enzymes from
the phz1 or phz2 operons is enriched in the ∆bfd cells. In comparison, the enzymes required for the
conversion of PCA to 5MPCA (PhzM) and then to PYO (PhzS) exhibit the same levels as in the wt
cells. To understand the consequences of this enrichment pattern on the production of phenazines,
we analyzed the total levels of PCA and PYO; 5MPCA was not analyzed due to being unstable [71].
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2.2. Inhibition of Iron Mobilization from BfrB Affects Central Carbon Metabolism and Amino Acid Biosynthesis
2.2. Inhibition of Iron Mobilization from BfrB Affects Central Carbon Metabolism and Amino Acid
Comparing the proteomic profiles of wt and ∆bfd cells shows significant differences in central
Biosynthesis
carbon metabolism, which extend to the synthesis of several amino acids (Figure 8). We begin this
Comparing the proteomic profiles of wt and Δbfd cells shows significant differences in central
discussion by pointing to the enrichment of enzymes involved in the conversion of glycogen to glucose
carbon metabolism, which extend to the synthesis of several amino acids (Figure 8). We begin this
(PA2152 and TreA) [72–74] in the ∆bfd cells. Glycogen is a major intracellular reserve polymer of the
discussion by pointing to the enrichment of enzymes involved in the conversion of glycogen to
α-1-4-linked glucose monomers that accumulates in bacterial cells under conditions of limited growth,
glucose (PA2152 and TreA) [72–74] in the Δbfd cells. Glycogen is a major intracellular reserve polymer
and it is degraded when carbon is limited [75–79]. As such, the enrichment of PA2152 and TreA in the
of the α-1-4-linked glucose monomers that accumulates in bacterial cells under conditions of limited
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∆bfd cells suggests alterations in carbon metabolism. Previous studies comparing the metabolic flux of
exponential phase Pseudomonas putida cells grown in iron replete vs. iron limiting conditions showed
a decrease in metabolic flux through the Entner–Doudoroff route, as well as through Fe-containing
metabolic enzymes of the tricarboxylic acid (TCA) cycle [80]. In agreement, our results show that
several enzymes of the cycle are depleted in the ∆bfd cells (Figure 8). Enzymes in the upper portion of
the TCA cycle which catalyze the conversion of pyruvate (AcoC, PA3417) or butanediol (AcoA, AcoB,
AcoC) to acetyl-CoA [81] are depleted in the ∆bfd cells. In addition, the aconitase enzymes AcnA and
PA0794, which depend on [4Fe-4S] catalytic centers to transform citrate to isocitrate via cis-aconitate,
are also depleted in the mutant cells. In the bottom section of the TCA cycle, the conversion of fumarate
to malate is probably affected by the depletion of FumA (an iron-dependent enzyme). The depletion
of FumA in the mutant cells appears to be compensated by the significant enrichment of FumC1,
an iron-independent fumarase hydratase, whose expression is known to be stimulated under iron
limiting conditions [82].
The iron starvation caused by blocking the BfrB–Bfd complex also affects amino acid biosynthesis.
Glycine plays an essential role as a precursor of proteins, nucleic acids and other metabolites. Glycine can
be produced from choline via glycine-betaine (GB) and sarcosine, or from serine, as schematically
depicted in Figure 8. P. aeruginosa can use GB as a sole source of carbon, nitrogen, and energy through
a series of successive demethylation reactions that produce Gly [83,84]. Although the reasons are
not yet clear, P. aeruginosa maintains intracellular pools of GB, the sizes of which are affected by the
main carbon source, temperature or salinity [85]. Our results indicate that the GB pool is affected by
iron limitation because both proteins required to convert GB to dimethylglycine (GbcA and GbcB)
are iron-dependent; GbcA is significantly depleted in the ∆bfd cells and GbcB was not detected.
The demethylation of dimethylglycine is catalyzed by DgcA and DgcB, and the product of the
reaction, sarcosine, is known to stimulate the sarcosine oxidation and utilization regulator (SouR),
thereby inducing the soxBDAG operon, along with a serine hydroxymethyl transferase (GlyA1) [86].
The SoxBDA enzymes catalyze the conversion of sarcosine to glycine, while GlyA1 catalyzes the
catabolism of glycine to serine. Consistent with the depletion of DgcA and probable relatively low
conversion of dimethylglycine to sarcosine in the mutant cells, the SoxBDA and GlyA1 enzymes are
also depleted (Figure 8), suggesting that the assimilation of GB and sarcosine to Gly and Ser is adversely
affected by the blockade of the BfrB–Bfd complex. As such, iron limitation in the ∆bfd cells adversely
affects the pathways that transform GB and sarcosine into metabolites used for energy production and
biosynthesis. It is probable that the sensitivity of this path to iron depletion starts with a fraction of the
iron-dependent enzymes unable to assemble functional catalytic centers, initially affecting sarcosine
biosynthesis, which in turn represses transcription of the SoxBDA and GlyA1 enzymes and affects the
biosynthesis of Gly and Ser.
The iron starvation elicited by blocking the BfrB–Bfd complex appears to also affect the biosynthesis
of several other amino acids whose structures are formed from intermediates in the TCA cycle. Ala,
Leu, Ile and Val are derived from pyruvate. The biosynthesis of Leu and Ile requires the large and
small subunits of the iron-dependent 3-isopropylmalate dehydratase (LeuC and LeuD) and PA3506,
which are depleted in the ∆bfd cells (Figure 8). The synthesis of Glu, Gln and Lys may also be impacted
by depletion of the iron-dependent aconitase enzymes AcnA and PA0794, required to transform citrate
to isocitrate. We used NMR spectroscopy (see Materials and Methods) to identify and measure the
relative concentrations of several of these amino acids in the wt and ∆bfd cells. The results from these
experiments (Figure 9, Table S3) demonstrate that the intracellular levels of Gly, Ala, Val, Leu, and Lys
are depleted in the ∆bfd cells. Consequently, the observations made by comparing the proteomic profiles
and the intracellular abundances of amino acids in the wt and ∆bfd cells provide strong support for the
idea that iron limitation resulting from blocking the BfrB–Bfd complex impacts carbon metabolism and
the biosynthesis of amino acids derived from metabolites in the carbon and citrate cycles.
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2.3. Inhibition of Iron Mobilization from BfrB Affects Proteins Involved in Respiration
The blockade of the BfrB–Bfd complex also affected the abundances of several proteins involved
in respiration (Figure 10), including the Anr (anaerobic regulation of arginine deaminase and nitrate
reduction) and Dnr (dissimilatory nitrate respiration) regulators, and proteins assembling the
membrane-bound and periplasmic nitrate reductases Nar and Nap. P. aeruginosa is well adapted for
microaerobic respiration due to its branched aerobic respiratory chain terminated by five terminal
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2.3. Inhibition of Iron Mobilization from BfrB Affects Proteins Involved in Respiration
The blockade of the BfrB–Bfd complex also affected the abundances of several proteins involved
in respiration (Figure 10), including the Anr (anaerobic regulation of arginine deaminase and
nitrate reduction) and Dnr (dissimilatory nitrate respiration) regulators, and proteins assembling the
membrane-bound and periplasmic nitrate reductases Nar and Nap. P. aeruginosa is well adapted for
microaerobic respiration due to its branched aerobic respiratory chain terminated by five terminal
oxidases; three are cytochrome c oxidases (cbb3-1, cbb3-2 and aa3), and two are cyanide-insensitive
quinol oxidases (Cyo and CIO) [87]. P. aeruginosa cells, which are thought to prefer microoxic
conditions, have been shown to grow at concentrations of dissolved oxygen less than 3 µM [88].
In fact, aerobically cultured P. aeruginosa cells block the transfer of O2 from the gas to the liquid phase,
inducing microoxic conditions for cells in exponential and stationary phase cultures [89]. Under these
conditions the regulator Anr stimulates transcription of cbb3-2, and is also responsible for the start
of denitrification via the regulator Dnr, although Dnr-dependent pathways are not essential at this
stage [90]. In the absence of O2 , P. aeruginosa can use nitrate and nitrogen oxides as terminal electron
acceptors. For this purpose, P. aeruginosa is equipped with three types of nitrate reductases: Nar,
a membrane-bound enzyme expressed during anaerobic growth with nitrate as the terminal electron
acceptor, Nap, a periplasmic enzyme expressed during the stationary growth phase in aerobic cultures,
and Nas, a cytoplasmic enzyme which allows P. aeruginosa to use nitrate as a nitrogen source [87].
During anaerobic growth using nitrate for respiration, Nar and the enzymes Nir, Nor and Nos carry out
the reduction of nitrate to N2 . The regulators controlling these processes include Anr, which responds
to low O2 tension, Dnr, which responds to Anr and nitric oxide (NO), and NarXL, which responds to
Anr and nitrate (Figure 10A). Anr, Dnr and NarXL stimulate the transcription of the narK1K2GHJI
operon encoding nitrate/nitrite transporters (NarK1 and NarK2) and the structural genes of Nar [91].
The nap operon is thought to be under the control of RpoS, and therefore it is expressed in the stationary
growth phase [87].
The Anr regulatory protein is enriched in the ∆bfd cells, whereas Dnr is depleted and NarXL
exhibits no change relative to the wild type cells (Figure 10). A possible interpretation of these
observations would suggest that the enrichment of Anr in the ∆bfd cells is in response to sensing lower
O2 tension than in their wt type counterparts. The depletion of Dnr and NarI proteins, as well as the
“normal” levels of NarXL, however, suggest that an alternative mechanism may be responsible for
the Anr enrichment in ∆bfd, whereby the iron limitation imposed by blocking the BfrB–Bfd complex
causes the accumulation of inactive Anr. In this context, it is important to note that Anr is an analog
of E. coli FNR (fumarate nitrate reductase regulator) [92]. To function as a transcriptional regulator,
FNR and Anr must be in dimeric form and harboring one O2 -sensitive [4Fe-4S] cluster per subunit.
Exposure to O2 causes iron loss from the [4Fe-4S] cluster, resulting in a cluster-free enzyme that
dissociates into monomers unable to bind DNA [93]. Importantly, E. coli cells grown aerobically have
been shown to contain significant amounts of apo-FNR [94], and the apo-FNR in these cells has been
shown to be relatively stable and actively recycled into a functional [4Fe-4S] dimer under iron-replete
conditions [95]. As such, the enrichment of Anr in the ∆bfd cells may be explained by the low iron and
low sulfur (see below) conditions that slow the incorporation of iron and sulfur into [4Fe-4S] clusters in
the existing and de novo synthesized Anr, causing the enzyme to accumulate in its inactive apo-form.
Evidence supporting this idea was obtained from analysis of the proteomic profile in the context of Anr
as a transcriptional activator of many genes in P. aeruginosa [96]. This analysis reveals that most of the
proteins coded by genes transcriptionally activated by Anr are depleted in the ∆bfd cells, despite the
enrichment of Anr (Figure 10B). Consequently, these observations support the hypothesis that iron
limitation caused by blocking the BfrB–Bfd complex impairs the efficient incorporation of iron sulfur
clusters into recycled or de novo synthesized apo-Anr.
It is also of interest to note that among the proteins coded by genes transcriptionally activated by
Anr but which are depleted in the ∆bfd cells, several are iron-dependent. Hemerythrin is a di-Fe center
protein thought to transport O2 in microoxic conditions [97], HemN is a [4Fe-4S] enzyme that functions
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as an O2 -independent coproporphyrinogen IX oxidase in heme biosynthesis, cytochrome c peroxidase
(CcpR) is a di-heme enzyme thought to function in the prevention of peroxide buildup in the cell [98],
and the cytoplasmic catalase KatA is a heme-containing enzyme that catalyzes peroxide decomposition
into water and O2 . The transcription of the katA gene is driven by two promoters; katAp1 is required
in the logarithmic growth phase, and katAp2, which is transcriptionally activated by Anr, is required
for KatA function in the stationary phase [99]. These observations suggest that the biosynthesis and
maturation of these important proteins is affected by low iron and sulfur, which limits the synthesis
of iron- and sulfur-containing cofactors, and by the accumulation of inactive Anr, which leads to the
repression of the corresponding genes.
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indicates that the mutant cells are deficient in sulfate or cysteine. The SSI proteins are coded by genes
in the spb-containing cysPTWA operon, where Sbp is a periplasmic sulfate-binding protein, CysP is a
periplasmic thiosulfate binding protein, CysT and CysW are the membrane proteins, and CysA is an
ATPase. That Sbp is highly enriched whereas CysP is not suggests that the Δbfd cells are actively
searching/importing SO2ି
4 [104]. The cytoplasmatic enzymes CysD and CysN, also enriched in the
mutant cells, catalyze the transformation of SO2ି
4 , first into adenylyl sulfate (APS) and then into 3′phosphoadenylyl sulfate (PAPS). PAPS is then transformed into sulfite (SOି ) by the enzyme CysH,
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which results in the accumulation of inactive Anr and the concomitant repression of genes that are
normally transcriptionally activated by functional Anr.
These findings also suggest that it is probable that other enzymes whose functions depend on
relatively sensitive [Fe-S] active centers can be affected similarly because the repair of the clusters
is slowed or impeded by iron and sulfur limitation. In support of these ideas, below we present
evidence suggesting that the blockade of the BfrB–Bfd complex also elicits a sulfur starvation response,
which is expected to adversely affect the construction and repair of the [Fe-S] centers important for
many crucial processes.
2.4. Inhibition of Iron Mobilization from BfrB Affects Assimilatory Sulfate Reduction and Sulfur Traffic
Sulfur, an essential element for bacterial life, is a component of the amino acids cysteine and
methionine. P. aeruginosa assimilates sulfur preferentially from sulfate (SO2−
4 ), which is imported
from the environment and reduced intracellularly to sulfide (S2− ) for its subsequent incorporation
into sulfur-containing molecules. A primary path of sulfur assimilation, the incorporation of S2− into
cysteine plays a crucial role in the biogenesis of [Fe-S] clusters, in the biosynthesis of antioxidant proteins
and peptides, and as a precursor of methionine, coenzyme A, coenzyme M, and also thiamine, biotin,
lipoic acid and the siderophore pyochelin [101,102]. Bacteria respond to sulfate or cysteine starvation
by deploying the so-called sulfate starvation-induced proteins (SSI proteins), which in P. aeruginosa
consist of sulfate and sulfonate transport systems for the uptake of sulfate and alkyl sulfonates, as well
as sulfatase and sulfonatase enzymes, which function in the reduction of the sulfate and alkylsulfonate
to S2− for its subsequent incorporation in cysteine [103]. In this context, it is interesting that many
of the SSI proteins are enriched in the ∆bfd cells (Figure 11A), because it indicates that the mutant
cells are deficient in sulfate or cysteine. The SSI proteins are coded by genes in the spb-containing
cysPTWA operon, where Sbp is a periplasmic sulfate-binding protein, CysP is a periplasmic thiosulfate
binding protein, CysT and CysW are the membrane proteins, and CysA is an ATPase. That Sbp is
highly enriched whereas CysP is not suggests that the ∆bfd cells are actively searching/importing
SO2−
4 [104]. The cytoplasmatic enzymes CysD and CysN, also enriched in the mutant cells, catalyze the
0
transformation of SO2−
4 , first into adenylyl sulfate (APS) and then into 3 -phosphoadenylyl sulfate
−
(PAPS). PAPS is then transformed into sulfite (SO3 ) by the enzyme CysH, and SO−
3 is subsequently
reduced to S2− by the NADPH-dependent sulfite reductase CysI, which requires siroheme and FAD to
function [105]. Equally consistent with a sulfur starvation response, the proteomic data indicate the
enrichment of TauA (taurine uptake) and enzymes PA3445 and PA2594, which function in the uptake
of alkanesulfonates [105] (Figure 11A).
The enrichment of proteins in the sulfate starvation response in the ∆bfd cells indicates that
the iron limitation imposed by blocking the BfrB–Bfd complex leads to SO2−
4 deficiency. Given that
2−
sulfur assimilation proceeds via the reduction of SO4 for the subsequent incorporation of a sulfur
atom from S2− in cysteine (and other organic molecules), the enrichment pattern suggests cysteine
deficiency in the ∆bfd cells. In this context, it is interesting that S2− (in equilibrium with HS−
and H2 S ) can be oxidized to sulfane sulfur (HSn H; n ≥ 1) by a sulfide:quinone oxidoreductase
enzyme [106,107]. The pertinent sulfide:quinone oxidoreductase enzyme in P. aeruginosa (PA2556)
is depleted in the ∆bfd cells (Figure 11A), an observation indicating that the ∆bfd cells prioritize S2− for
cysteine biosynthesis. Additional evidence supporting the idea of cysteine deficiency was obtained
from the NMR spectroscopic analysis, which shows that the levels of cysteine (measured as cystine)
and glutathione (measured as oxidized form) in the ∆bfd cells are ~30–40% of those in the wt cells
(Figure 9). It is therefore clear that the iron starvation induced by blocking the BfrB–Bfd complex leads
to cysteine deficiency in P. aeruginosa. Cysteine deficiency in the iron-starved ∆bfd cells is probably a
consequence of several processes, including but not restricted to: (i) the overproduction of pyochelin,
which requires two cysteine molecules in its biosynthesis, (ii) the stress caused by an abundance of
phenazines, such as the high-redox potential PCA, which induces oxidative stress and therefore the
faster turnover and damage of sulfur-dependent oxidative stress defense molecules, such as glutathione
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and thioredoxin, and (iii) the repair and de novo synthesis of [Fe-S] clusters oxidized by the abundance
of high-redox potential phenazines.
Additional evidence indicating that iron starvation in the ∆bfd cells affects sulfur management
stems from observations regarding the biosynthesis of cofactors containing sulfur atoms, such as biotin,
thiamine, and tRNA thiolation (Figure 11B). In the final step of biotin biosynthesis, the incorporation
of a sulfur atom requires biotin synthase (BioB), which is enriched in the ∆bfd cells. The sulfur atom
incorporated into biotin is donated from a [2Fe-2S] cluster in BioB, which leads to cluster loss and
inactive enzyme, followed by an iron- and sulfur-dependent repair mechanism that installs a new
[2Fe-2S] cluster in BioB [108]. As such, it is possible that the iron and sulfur deficiencies in the ∆bfd cells
lead to an enrichment of BioB as a mixture of active and inactive forms. The enzyme PA2062, a cysteine
desulfurase akin to IscS, is implicated in thiamine metabolism and is highly enriched in the ∆bfd cells
(Figure 11B). Some organisms have more than one copy of cysteine desulfurase, which play pivotal
roles in the initial stages of sulfur trafficking within cells. These enzymes extract a sulfur atom from
cysteine to form a persulfide intermediate, which is subsequently incorporated into the biosynthetic
pathways leading to the formation of [Fe-S] clusters and sulfur-containing biofactors [109]. The enzyme
MiaB, depleted in the ∆bfd cells, catalyzes the posttranscriptional thiolation of a subset of tRNAs,
a process required for their maturation. MiaB harbors two essential [4Fe-4S] clusters, which catalyze
the insertion of a sulfur atom into isopentenyl adenosine to produce 2-methylthio-6-isopentenyl
adenosine [110] (Figure 11B).
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[27,30].
Accordingly,
blocking
iron
mobilization
inhibition of iron mobilization from bacterioferritin. Iron mobilization from BfrB in P. aeruginosa

requires the formation of a specific complex with Bfd (Figure 1) [27,30]. Accordingly, blocking iron
mobilization from BfrB by deletion of the bfd gene (Δbfd) “locks” iron in the bacterioferritin [16] and
impairs biofilm formation [14]. These findings encouraged the development of novel small molecule
inhibitors of the BfrB–Bfd complex, which constrain P. aeruginosa cell growth and potentiate the
activity of the fluoroquinolone antibiotics [10]. Culturing Δbfd cells, or wt cells in the presence of an
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from BfrB by deletion of the bfd gene (∆bfd) “locks” iron in the bacterioferritin [16] and impairs biofilm
formation [14]. These findings encouraged the development of novel small molecule inhibitors of
the BfrB–Bfd complex, which constrain P. aeruginosa cell growth and potentiate the activity of the
fluoroquinolone antibiotics [10]. Culturing ∆bfd cells, or wt cells in the presence of an inhibitor of the
BfrB–Bfd complex, leads to pyoverdine overproduction, which has been interpreted to suggest that
“locking” iron in BfrB causes intracellular iron limitation [10,16]. Although pyoverdine overproduction
indeed suggests iron limitation, secretion of the siderophore may occur independently of its regulation
by intracellular iron levels [20], and does not per se indicate the extent of intracellular iron limitation,
or if such limitation affects cellular fitness.
We conducted this work to investigate if the deletion of the bfd gene elicits iron homeostasis
dysregulation and if the lesion in iron metabolism (∆bfd) affects metabolic homeostasis in P. aeruginosa.
The results unequivocally show that the ∆bfd cells experience severe iron limitation, as is evident not
only in the overexpression of proteins involved in siderophore biosynthesis, but also in the enrichment
of proteins involved in heme uptake/utilization, and AQ and phenazine biosynthesis. The analytical
quantification of pyoverdine, AQs and phenazines corroborated our interpretation of the proteomic
response and demonstrated that all these metabolites are produced at significantly higher levels in the
∆bfd cells. In the context of the intracellular iron starvation that ensues in the ∆bfd cells, it is important
to underscore that the cells were cultured in iron-replete media (10 µM Fe), so the acute iron starvation
that develops in the ∆bfd cells is a direct consequence of iron flowing unidirectionally into BfrB.
In addition to demonstrating global iron limitation, the proteomic profiles show that the
lesion in iron metabolism caused by locking iron in BfrB adversely affects important metabolic
pathways, including carbon metabolism, amino acid biosynthesis, respiration, and sulfur metabolism.
Iron limitation caused by inhibiting iron mobilization from BfrB appears to affect these paths in at
least two predominant ways, as follows: (i) It affects the abundance of iron-dependent proteins,
which in turn affect the regulation and abundance of other proteins participating in the same metabolic
pathways. (ii) It elicits an overproduction of high-potential phenazines, which induce oxidative
stress and consequently damage to [Fe-S] clusters and sulfur-dependent oxidative stress defense
molecules, such as glutathione and thioredoxin. The increased demand for sulfur needed to repair
[Fe-S] clusters and sulfur-dependent molecules probably overwhelms the sulfur homeostasis machinery,
as is suggested by the depleted levels of cysteine and glutathione in the ∆bfd cells.
Finally, it is interesting to compare the findings reported herein with results from a study by
Nelson et al. comparing the proteomic responses of wt P. aeruginosa PAO1 cells cultured in Fe-rich and
Fe-deficient media [111]. It is important to underscore that in the study by Nelson et al., the cellular
response to low iron was investigated by comparing the proteomic response of wt cells with intact
iron homeostasis machinery cultured in high vs. low iron conditions. In comparison, in this study
we compare the proteomic response of wt cells with that of ∆bfd cells, which have a lesion in the iron
homeostasis machinery. In addition, in this study the cells were cultured under iron-replete conditions;
intracellular iron limitation in the ∆bfd cells develops because intracellular iron is locked in BfrB.
A comparison of the proteins detected in each of the studies and their corresponding abundances is
presented in Table S2. Although in both studies iron limitation elicits the deployment of siderophores
and heme acquisition/utilization systems, considering the differences observed in the two studies is
insightful. In the wt cells cultured under low iron conditions (Nelson et al.), the proteins involved
in sulfate and sulfonate assimilation, the reduction of the oxo-anions to sulfite and sulfide, and the
biosynthesis of cysteine, are depleted [111]. In stark contrast, these proteins are enriched in the ∆bfd
cells (Figure 11). A second significant difference is in phenazine biosynthesis. While in the wt cells
cultured in low iron conditions the proteins involved in phenazine biosynthesis are depleted [111],
these proteins are enriched in the ∆bfd cells (Figure 7). Considering these two significant differences
supports the detrimental consequences of dysregulating iron homeostasis by blocking the BfrB–Bfd
complex; the overproduction of phenazines in the ∆bfd cells leads to oxidative stress, which in
turn damages [Fe-S] clusters and sulfur-containing antioxidant molecules. This situation imposes
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a very difficult-to meet-demand for sulfur and iron assimilation, which ultimately results in low
levels of cysteine, antioxidant molecules and sulfur- and iron-dependent molecules (Figure 9 and
Table S1). These observations lead us to hypothesize that small molecule inhibitors of the BfrB–Bfd
complex, by virtue of eliciting an irreversible accumulation of iron in BfrB, would trigger a homeostatic
dysregulation akin to that reported here for the ∆bfd cells, thus encouraging the development of
inhibitors of the BfrB–Bfd complex for possible therapeutic applications.
4. Materials and Methods
4.1. Strains, Media and Growth Conditions
Chemicals were purchased from Fisher Scientific (Waltham, MA, USA) unless otherwise stated.
P. aeruginosa (PA01) was purchased from the University of Washington Genome center (Seattle,
WA, USA). The PA01-derived strain with an unmarked, in-frame deletion of the bfd gene (∆bfd)
had been prepared previously [16]. All strains were maintained on Pseudomonas Isolation Agar (PIA,
BD Biosciences, San Jose, CA, USA). Pseudomonas aeruginosa isolation (PI) media was used to culture
cells. PI media contains 20 g L−1 peptone, 1.4 g L−1 MgCl2 ·6H2 O, 10 g L−1 K2 SO4 , 25 mg L−1 irgasan
(Sigma-Aldrich, St. Louis, MO, USA), and 20 mL L−1 glycerol, pH 7.0. PI media was supplemented
with 10 µM iron using a 10 mM stock of (NH4 )2 Fe(SO4 )2 (pH~2.0).
4.2. Cell Growth and Preparation of Lysate Solution
Pre-cultures (5 mL) of wild type (wt) and ∆bfd P. aeruginosa cells were grown in PI media for 12 h
in 50 mL conical tubes covered with an air-permeable membrane at 37 ◦ C and 220 rpm. The cells were
centrifuged at 4000 rpm for 10 min and the cell pellets washed twice with PI media not supplemented
with iron. The cell pellets were resuspended in PI media supplemented with 10 µM iron, diluted in
the same media to an optical density at 600 nm (OD600 ) = 0.001, and 50 mL of the cell suspension
was transferred to 250 mL polypropylene Erlenmeyer flasks. The flasks were covered with an air
permeable membrane and incubated for 30 h at 37 ◦ C and 230 rpm. A small volume was sampled
for enumeration of viable cells prior to harvesting the cells by centrifugation (4000 rpm, 15 min and
4 ◦ C). The cell pellets were washed twice with 10 mL of phosphate buffer saline (PBS) and stored at
−20 ◦ C overnight. The cell pellets were re-suspended in 5 mL 1% SDS in water and sonicated for 90 s
in a Qsonica Q500 sonicator operating at a 20% pulse amplitude, alternating 10 s pulse-on and 10 s
pulse-off. The resultant lysate solutions were stored at −20 ◦ C until further analysis. The cell-free
supernatants were analyzed for pyoverdine using a previously reported protocol [16].
4.3. Sample Preparation and Proteomics Workflow
These were carried out by following the published protocols developed at the Proteomics Core
Facility, Louisiana State University Health Science Center, New Orleans [112]. Three biological replicates
were conducted each for the wt and ∆bfd cells. Briefly, 100 µg of protein per sample was used for
trypsin digestion. The protein concentration was determined with the aid of BCA protein assay kit
(Pierce, Thermo Scientific, Rockford, IL, USA) using an eight-point BSA standard curve. Proteins were
reduced using 10 mM tris(carboxyethyl)phosphine (TCEP) for 1 h at 55 ◦ C, and subsequently alkylated
with 20 mM iodoacetamide for 30 min at room temperature in the dark. Proteins were subjected to
chloroform-methanol precipitation, and the resultant pellet was digested with 2 µg of sequencing grade
trypsin at 37 ◦ C overnight. The next day, tryptic peptides were labeled with a TMT 6plex reagents
set (Thermo Scientific) according to the manufacturer’s recommended protocol. The tagged samples
were stored at −80 ◦ C until analysis. An equal volume from each TMT tagged sample was pooled
into a single tube and purified using acidic reverse phase conditions (SepPak-Waters, Milford, MA,
USA). Once the samples were dried, a fractionation step was carried out to lower the complexity of
the sample. The sample volume was adjusted to 115 µL by 20 mM ammonium hydroxide (pH 10),
and basic-pH reverse phase chromatography (Dionex U3000, Thermo Scientific, West Palm Beach, FL,
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USA) was carried out according to the parameters below. The injection volume was 100 µL, and the
flow rate was 0.1 mL/min. A 90 min gradient was developed from 10 mM ammonium hydroxide
(pH = 10) to 100% acetonitrile (pH = 10). A total of 48 200 µL fractions were collected, and the fractions
were re-combined in a checkerboard fashion (fraction 1, 13, 25, and 37—super fraction 1; fractions 2, 14,
26, 38—super fraction 2, etc.), resulting in 12 ‘super fractions’. These fractions were run on a Dionex
U3000 nanoflow coupled to a Thermo Scientific™ Orbitrap Fusion™ Tribrid™ Mass Spectrometer
(Thermo Scientific). Liquid chromatography was performed at a flow rate of 0.3 µL/min (Trap column:
C18 PepMap 100, 5 µm, 100 Å; separation column: PicoChip REPROSIL-Pur C18-AQ, 3 µm, 120 Å,
105 mm). A 90 min chromatographic method was employed. The gradient was as follows: 2–25%
ACN in 0.1% formic acid (FA)-65 min, 50% ACN/FA-10 min, 90% ACN/FA-5 min, and re-equilibration
2% ACN/FA-10 min.
Electrospray ionization was performed at 2.6 kV. Data acquisition used an MS3 approach;
survey scans were performed in the Orbitrap, using a resolution of 120,000. MS2 scans were done
in the linear ion trap, using a collision-induced dissociation of 25%. For the fragmentation of the
TMT-reporter ions, high-energy collision dissociation (HCD) of 65% was used and detected in the
Orbitrap using a 30,000 resolution. Runs were done in triplicate for each super fraction.
TMT data were analyzed using Proteome Discoverer 2.2. The triplicate runs for the 12 super
fractions were merged and searched against SEQUEST. The parameters for searching included
static modifications of TMT reagents on lysine and N-terminus (+229.163), carbamidomethyl on
cysteines (=57.021), and the dynamic modification of methionine oxidation (=15.9949), two maximum
trypsin missed-cleavages, parent ion tolerance—10 ppm, and the fragment mass tolerance—0.6 Da.
High-scoring peptides were considered using a false discovery rate of 1%. Data files were searched
against the Pseudomonas Genome Database (www.Pseudomonas.com).
4.4. Data Analysis
A volcano plot was generated using the log2 (fold change) and the -log10 (abundance ratio p-values).
Data were filtered based on the fold change, and the abundance ratio p-values. Proteins exhibiting a
(∆bfd)/(wild type) fold change ≥1.4 and ≤0.7, and the abundance ratio p-value < 0.05, are considered to be
differentially expressed [34]. The filtered datasets were uploaded onto the Kyoto Encyclopedia of Genes
and Genomes (KEGG) Pathway Mapper and searched against P. aeruginosa (PA01) organism-specific
pathways [113]. Identified proteins in the KEGG mapper were also searched against the Pseudomonas
genome database (https://www.pseudomonas.com) and UniProt (https://www.uniprot.org) to obtain
functional predictions and classifications [36].
4.5. NMR Analysis of Metabolites
Pseudomonas aeruginosa PAO1 cells (three biological replicates) were cultured and harvested
as described above. The harvested cells were resuspended in 1.25 mL of HPLC-grade methanol
(OmniSolv), incubated for 30 min at ambient temperature and then centrifuged for 30 min at 4000 rpm
and 4 ◦ C. The supernatants were transferred to separation funnels containing 1.25 mL of deionized
water and then extracted with 2.5 mL of chloroform. The aqueous phase was frozen at −80 ◦ C and
freeze-dried with the aid of a SpeedVac concentrator (Thermo SAVANT, SPD111V) overnight. The dry
powder was dissolved in 550 µL of PBS (pH 7.4) prepared in D2 O (99.8%) containing 0.01% (w/v)
3-(Trimethylsilyl) propane-1-sulfonate, sodium salt (DSS) for chemical shift referencing. The solutions
were vortexed and centrifuged and then transferred to 5 mm NMR tubes.
NMR spectra were acquired at 298 K on a Bruker Avance III 800 MHz spectrometer equipped
with a 5 mm TCI cryoprobe. One-dimensional 1 H NMR spectra were acquired (128 scans) using the
1D-NOESY experiment and pre-saturation of the water peak, with a spectral width of 16,000 Hz,
65 K data point, 2.0 s acquisition time and 1.0 s relaxation delay. Spectra were apodized with a
0.3 Hz line broadening prior to Fourier transformation. 1 H-13 C HSQC (heteronuclear single quantum
correlation) spectra were acquired with a spectral width of 8000 Hz, 4096 data points and 1.0 s
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relaxation delay in the direct-detected dimension (128 scans), and 512 data points over a spectral
width of 36,000 Hz in the indirect-detected dimension. 1 H-1 H TOCSY (total correlation spectroscopy)
spectra were acquired with a spectral width of 8000 Hz, 4096 data points and 1.0 s relaxation delay
(16 scans) in the direct-detected dimension, and 256 datapoints over a spectral with of 8000 Hz in the
indirect-detected dimension. Adjustments to the baseline, peak phasing and chemical shift referencing
were made using Bruker Topspin 3.6.2. To identify the identity of metabolites, the chemical shifts
in the NMR spectra were compared to the Biological Magnetic Resonance Database [114] and the
Human Metabolome Database [115] for positive matches. To corroborate metabolite identifications
the chemical shifts were correlated using the 1 H-13 C HSQC and the 1 H-1 H TOCSY spectra (Table S3).
Combining the information from the 1D and 2D NMR spectra greatly reduced the ambiguity of
assigning chemical shifts to metabolites. The volumes of judiciously chosen peaks in the 1 H-13 C HSQC
spectra were integrated and used to compare the relative levels of metabolites in the wt and ∆bfd cells.
The average and standard deviations obtained from 3 biological replicates have been summarized in
Figure 9. The statistical significance between the means and standard deviations of values comparing
the levels of metabolites in the wt and ∆bfd cells was determined using Student’s t test with the aid of
SigmaPlot (Systat Software, Inc. San Jose, CA, USA).
4.6. Analysis of 2—Alkyl-4-Quinolones (AQs)
The HHQ, PQS and HQNO extracted from bacterial cells and cell culture supernatants were
quantitated with the aid of liquid chromatography—mass spectrometry using a previously described
method [14]. In brief: For the analysis of AQs in bacterial cells, a 1.0 mL sample of bacterial cell culture
was centrifuged and the cell pellets resuspended in 3 mL HPLC-grade methanol. For the analysis in
spent media, 3 mL of cell culture were clarified by centrifugation. The solutions were acidified with
15 µL 12 N HCl, extracted into 6 mL of ethyl acetate and incubated at ambient temperature for 1 h
with slow shaking. The organic layers were separated by centrifugation, transferred to new micro
centrifuge tubes, and evaporated overnight using a SpeedVac Concentrator. Quantitative analysis was
performed using an LC-MS system comprising an Agilent 1260 Infinity II HPLC and an Agilent 6230
time-of-flight mass spectrometer operating in the positive ion mode with a capillary voltage of 4000 V,
end plate voltage of 150 V, and nebulizing gas (N2 ) temperature of 325 ◦ C. Samples were separated in
a Poroshell 120 EC-C8 column (3.0 × 100 mm, 2.7 µm particle size, 120 Å pore size; Agilent) with a
0.4 mL/min flow rate and the following gradient: 97% A (2 min), 63% A (5 min), 57% A (21 min),
and 3% A (31 min), revert to the initial conditions and equilibrate for 11 min; A: 0.1% formic acid in
water. B: 0.1% formic acid in acetonitrile. AQs were detected using full scan mode (m/z 130 to 350)
and quantitated by measuring the integrated peak area of the corresponding [M + H]+ ions and a
standard curve constructed from commercially available HHQ, HQNO, and PQS.
4.7. Analysis of Phenazine 1-Carboxylic Acid (PCA) and Pyocyanin (PYO)
The cell suspension (3 mL) was acidified to pH 4.0 with HCl prior to extraction with 6 mL of
ethyl acetate. The ethyl acetate extracts were kept at room temperature for 30 min with gentle shaking
prior to centrifugation at 4 ◦ C and 4000 rpm for 10 min. The ethyl acetate layer was transferred to
new microcentrifuge tubes and evaporated with the aid of a Speed Vac Concentrator. Dried samples
were resuspended in 300 µL of methanol and stored at −20 ◦ C. Quantitative determination was carried
out by LC-MS using an Agilent 6230 TOF Ms (see above) in the positive ion mode. Samples were
separated in a Poroshell 120 EC-C18 column (2.1 × 100 mm, 2.7 µm particle size, 120 Å pore size;
Agilent) using a flow rate of 0.4 mL/min and the following gradient: 95% A (2 min), 40% A (11 min),
5% A (26 min), and reequilibration to initial conditions (11 min); A = 0.1% formic acid in water,
B = 0.1% formic acid in acetonitrile. Phenazines were detected using full scan mode (m/z 130 to 350)
and quantitated by measuring the integrated peak area of the corresponding [M + H]+ ions and a
standard curve constructed using commercially available PCA (Evo Blocks Ltd., Budapest, Hungary)
and PYO (Cayman Chemical, Ann Arbor, MI, USA).
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